首页 > 最新文献

Current Indian Science最新文献

英文 中文
Moisture Determination in CO2 Gas Cylinders for Application in Annulus GasMonitoring Systems of Pressurized Heavy Water Reactors (PHWRs) 用于压水重水反应堆 (PHWR) 环空气体监测系统的二氧化碳气瓶中的水分测定
Pub Date : 2023-12-13 DOI: 10.2174/012210299x254766231115104920
N. Raje, S. Kolay
Critical monitoring of moisture content in annulus gas is required due to its detrimental effect on the pressure tube, leading to surface corrosion andfinally the rupture of the pressure tube.The present work describes a simple and reliable thermo-analytical method for the quantitative determination of moisture in CO2 gas cylinders,using anhydrous barium chloride as the novel adsorbent material and simultaneous.Thermogravimetry - Differential Thermal Analysis - Evolved Gas Analysis (Fourier Transformed InfraRed Spectroscopy) [TG-DTA-EGA(FTIR)]as determination techniques.Differential Scanning Calorimetry (DSC) coupled with Microscopy has been used to see the surface morphological variations during the heattreatment. The results of these studies are being discussed here.
本研究介绍了一种简单可靠的热分析方法,用于定量测定二氧化碳气瓶中的水分,该方法采用无水氯化钡作为新型吸附材料,并同时采用热重分析法、差热分析法、气体进化分析法(傅立叶变换红外光谱法)[TG-DTA-EGA(FTIR)]作为测定技术。差示扫描量热法(DSC)与显微镜相结合,用于观察热处理过程中的表面形态变化。本文将讨论这些研究的结果。
{"title":"Moisture Determination in CO2 Gas Cylinders for Application in Annulus Gas\u0000Monitoring Systems of Pressurized Heavy Water Reactors (PHWRs)","authors":"N. Raje, S. Kolay","doi":"10.2174/012210299x254766231115104920","DOIUrl":"https://doi.org/10.2174/012210299x254766231115104920","url":null,"abstract":"\u0000\u0000Critical monitoring of moisture content in annulus gas is required due to its detrimental effect on the pressure tube, leading to surface corrosion and\u0000finally the rupture of the pressure tube.\u0000\u0000\u0000\u0000The present work describes a simple and reliable thermo-analytical method for the quantitative determination of moisture in CO2 gas cylinders,\u0000using anhydrous barium chloride as the novel adsorbent material and simultaneous.\u0000\u0000\u0000\u0000Thermogravimetry - Differential Thermal Analysis - Evolved Gas Analysis (Fourier Transformed InfraRed Spectroscopy) [TG-DTA-EGA(FTIR)]\u0000as determination techniques.\u0000\u0000\u0000\u0000Differential Scanning Calorimetry (DSC) coupled with Microscopy has been used to see the surface morphological variations during the heat\u0000treatment. The results of these studies are being discussed here.\u0000","PeriodicalId":479738,"journal":{"name":"Current Indian Science","volume":"55 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139003704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential Therapeutic Role of Cannabinoid System in Alzheimer’s Disease: AReview 大麻素系统在阿尔茨海默病中的潜在治疗作用综述
Pub Date : 2023-12-13 DOI: 10.2174/012210299x256030231114114815
Abrar Ahmad Zargar, Ranjeet Kumar, Arvind Kumar, Ruby Gangwar, Amit Sharma
The purpose of the study was to investigate the role of the endocannabinoid system and the therapeutic potential benefits of cannabinoids inAlzheimer’s disease. The most frequent form of dementia in older individuals is Alzheimer's disease (AD), a progressive neurological ailment thatgradually deprives people of their memory, cognitive abilities, and, ultimately, their ability to perform daily tasks. Alzheimer's disease isdistinguished by a progressive deterioration in cognitive function, which includes a decline in memory, learning capacity, and thinking power. Thehuman body's endocannabinoid system functions as a channel for cell communication. It is a neurotransmission system that is present in variousregions of the body and tissues as well as assists in the control of a number of metabolic processes. Endocannabinoids, enzymes, and cannabinoidreceptors all play a role in managing a variety of biological functions. In this review, we aimed to summarize the endocannabinoid system, theeffect of beta-amyloid, tau-protein accumulation and neuroinflammation, potential therapeutic benefits of cannabinoids, current pre-clinical andclinical evidence for the potential therapeutic benefits, limitations, and challenges, and potential future research in the field. Emerging scientificdata suggests that the ECS (Endocannabinoid system) is linked to neurodegenerative illnesses and that altering its tone may be a usefultherapeutic strategy for the treatment of AD (Alzheimer’s disease).
这项研究的目的是调查内源性大麻素系统的作用以及大麻素对阿尔茨海默病的潜在治疗效果。阿尔茨海默病(AD)是老年人最常见的痴呆症,是一种渐进性神经系统疾病,会逐渐剥夺人们的记忆力和认知能力,并最终丧失完成日常任务的能力。阿尔茨海默病的特征是认知功能逐渐退化,包括记忆力、学习能力和思维能力下降。人体的内源性大麻素系统是细胞交流的渠道。它是一种神经传递系统,存在于人体的各个区域和组织中,并协助控制一些新陈代谢过程。内源性大麻素、酶和大麻素受体都在管理各种生物功能方面发挥作用。在这篇综述中,我们旨在总结内源性大麻素系统、β-淀粉样蛋白、tau 蛋白积累和神经炎症的影响、大麻素的潜在治疗功效、当前潜在治疗功效的临床前和临床证据、局限性和挑战,以及该领域未来的潜在研究。新出现的科学数据表明,ECS(内源性大麻素系统)与神经退行性疾病有关,改变其调节可能是治疗 AD(阿尔茨海默病)的一种有用的治疗策略。
{"title":"Potential Therapeutic Role of Cannabinoid System in Alzheimer’s Disease: A\u0000Review","authors":"Abrar Ahmad Zargar, Ranjeet Kumar, Arvind Kumar, Ruby Gangwar, Amit Sharma","doi":"10.2174/012210299x256030231114114815","DOIUrl":"https://doi.org/10.2174/012210299x256030231114114815","url":null,"abstract":"\u0000\u0000The purpose of the study was to investigate the role of the endocannabinoid system and the therapeutic potential benefits of cannabinoids in\u0000Alzheimer’s disease. The most frequent form of dementia in older individuals is Alzheimer's disease (AD), a progressive neurological ailment that\u0000gradually deprives people of their memory, cognitive abilities, and, ultimately, their ability to perform daily tasks. Alzheimer's disease is\u0000distinguished by a progressive deterioration in cognitive function, which includes a decline in memory, learning capacity, and thinking power. The\u0000human body's endocannabinoid system functions as a channel for cell communication. It is a neurotransmission system that is present in various\u0000regions of the body and tissues as well as assists in the control of a number of metabolic processes. Endocannabinoids, enzymes, and cannabinoid\u0000receptors all play a role in managing a variety of biological functions. In this review, we aimed to summarize the endocannabinoid system, the\u0000effect of beta-amyloid, tau-protein accumulation and neuroinflammation, potential therapeutic benefits of cannabinoids, current pre-clinical and\u0000clinical evidence for the potential therapeutic benefits, limitations, and challenges, and potential future research in the field. Emerging scientific\u0000data suggests that the ECS (Endocannabinoid system) is linked to neurodegenerative illnesses and that altering its tone may be a useful\u0000therapeutic strategy for the treatment of AD (Alzheimer’s disease).\u0000","PeriodicalId":479738,"journal":{"name":"Current Indian Science","volume":"57 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139005944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nano Lipid Carriers: A Novel Approach for Nose to Brain Drug Delivery 纳米脂质载体:鼻脑给药新方法
Pub Date : 2023-12-13 DOI: 10.2174/012210299x260333231120025251
Bhavishya Tyagi, Madhu Verma
A nanostructured lipid carrier (NLC) is a nanoparticulate carrier system consisting of solid lipids, liquid lipids, surfactants, and water. NLCs aresecond-generation lipid nanocarriers, gained continuous significance in recent times, and possess better physical stability, increased drug loading,improved permeability, and bioavailability. They are considered superior to many other traditional lipid-based nanocarriers such as nanoemulsion,liposomes, and solid lipid nanoparticles (SLN) and have emerged as an alternative to first-generation nanoparticles (SLN). NLCs have significantpotential in the pharmaceutical industry due to their extensive beneficial effects, like drug targeting, enhanced bioavailability, and their widepositive benefits.The primary aim of this review was to study and explore the Nano lipid carrier, its advantages, patent preferences, and advancement of NLCs usein nose-to-brain drug deliveryThe objective of this study was to conduct a literature review on the development of NLC for nose-to-brain drug delivery. The review focused onNLC, its significant role in nose-to-brain delivery, and relevant patents. To achieve this goal, different review articles searched, were studied, andsummarized from various sources such as research articles, review articles, books, scientific reports, and patents.This review article discusses the potential benefits of NLCs in brain-targeting drug delivery through the intranasal route and key aspects of NLCs,including their structure composition, formulation technique, and characterization, which are crucial for developing a reliable drug delivery.
纳米结构脂质载体(NLC)是一种由固体脂质、液体脂质、表面活性剂和水组成的纳米颗粒载体系统。纳米脂质载体是第二代脂质纳米载体,具有更好的物理稳定性、更高的载药量、更好的渗透性和生物利用度,近年来不断受到重视。它们被认为优于许多其他传统的脂质纳米载体,如纳米乳液、脂质体和固体脂质纳米颗粒(SLN),并已成为第一代纳米颗粒(SLN)的替代品。本综述的主要目的是研究和探讨纳米脂质载体、其优势、专利偏好以及纳米脂质载体在鼻脑给药中的应用进展。综述的重点是 NLC、其在鼻脑给药中的重要作用以及相关专利。本综述文章讨论了 NLC 在通过鼻内途径进行脑靶向给药方面的潜在优势,以及 NLC 的关键方面,包括其结构组成、配制技术和表征,这些对于开发可靠的给药至关重要。
{"title":"Nano Lipid Carriers: A Novel Approach for Nose to Brain Drug Delivery","authors":"Bhavishya Tyagi, Madhu Verma","doi":"10.2174/012210299x260333231120025251","DOIUrl":"https://doi.org/10.2174/012210299x260333231120025251","url":null,"abstract":"\u0000\u0000A nanostructured lipid carrier (NLC) is a nanoparticulate carrier system consisting of solid lipids, liquid lipids, surfactants, and water. NLCs are\u0000second-generation lipid nanocarriers, gained continuous significance in recent times, and possess better physical stability, increased drug loading,\u0000improved permeability, and bioavailability. They are considered superior to many other traditional lipid-based nanocarriers such as nanoemulsion,\u0000liposomes, and solid lipid nanoparticles (SLN) and have emerged as an alternative to first-generation nanoparticles (SLN). NLCs have significant\u0000potential in the pharmaceutical industry due to their extensive beneficial effects, like drug targeting, enhanced bioavailability, and their wide\u0000positive benefits.\u0000\u0000\u0000\u0000The primary aim of this review was to study and explore the Nano lipid carrier, its advantages, patent preferences, and advancement of NLCs use\u0000in nose-to-brain drug delivery\u0000\u0000\u0000\u0000The objective of this study was to conduct a literature review on the development of NLC for nose-to-brain drug delivery. The review focused on\u0000NLC, its significant role in nose-to-brain delivery, and relevant patents. To achieve this goal, different review articles searched, were studied, and\u0000summarized from various sources such as research articles, review articles, books, scientific reports, and patents.\u0000\u0000\u0000\u0000This review article discusses the potential benefits of NLCs in brain-targeting drug delivery through the intranasal route and key aspects of NLCs,\u0000including their structure composition, formulation technique, and characterization, which are crucial for developing a reliable drug delivery.\u0000","PeriodicalId":479738,"journal":{"name":"Current Indian Science","volume":"70 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139003142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digitalis Purpurea: Hope for Myocardial Infarction Induced By Obesity - AReview 紫洋地黄:肥胖症诱发心肌梗死的希望 - AReview
Pub Date : 2023-12-13 DOI: 10.2174/012210299x261528231116134608
Kusum Passi, Ranjeet Kumar, Dipasha Khurana, Naman Dhanda
Digitalis purpurea L. belongs to the Scrophulariaceae family. The most significant is digitoxin, a very toxic substance that builds up in the bodyand is impenetrable in water. For millennia, people have utilized the medication Digitalis to treat cardiac problems induced by obesity. Externaltriggers like strenuous exercise, emotional stress, eating, exposure to extreme weather, sexual activity, coffee and alcohol consumption, and use ofcocaine or marijuana temporarily increase the risk of having a myocardial infarction. A person's genetic makeup influences disease progression, thepresence of chronic risk factors, and lifestyle choices. Despite various educational programs, the fight against obesity does not appear to besuccessful. According to WHO (World Health Organisation) statistics, 13 percent of adults over the age of 18 are obese, and 39 percent areoverweight. Being overweight or obese significantly raises the chance of developing disorders, including coronary heart disease. Digitalis isprimarily used to treat heart conditions. It encourages and stimulates the action of all muscle tissues in cases of clogged heart failure. The herbimproves heart nutrient absorption by forcing more blood into the coronaries. Digitalis aids in the repair and regulation of the heart's function whenblood circulation is hampered.
紫洋地黄属于景天科。其中最重要的成分是地高辛,它是一种剧毒物质,会在体内积聚,在水中无法渗透。千百年来,人们利用洋地黄这种药物来治疗肥胖引起的心脏问题。剧烈运动、情绪紧张、进食、暴露于极端天气、性活动、饮用咖啡和酒精以及使用可卡因或大麻等外部诱因会暂时增加患心肌梗塞的风险。一个人的基因构成会影响疾病的进展、慢性危险因素的存在以及生活方式的选择。尽管开展了各种教育计划,但与肥胖症的斗争似乎并不成功。根据世界卫生组织(WHO)的统计数据,18 岁以上的成年人中有 13% 肥胖,39% 超重。超重或肥胖会大大增加患冠心病等疾病的几率。洋地黄主要用于治疗心脏疾病。在心力衰竭堵塞的情况下,它能促进和刺激所有肌肉组织的活动。这种草药能迫使更多血液进入冠状动脉,从而改善心脏对营养物质的吸收。当血液循环受阻时,洋地黄有助于修复和调节心脏功能。
{"title":"Digitalis Purpurea: Hope for Myocardial Infarction Induced By Obesity - A\u0000Review","authors":"Kusum Passi, Ranjeet Kumar, Dipasha Khurana, Naman Dhanda","doi":"10.2174/012210299x261528231116134608","DOIUrl":"https://doi.org/10.2174/012210299x261528231116134608","url":null,"abstract":"\u0000\u0000Digitalis purpurea L. belongs to the Scrophulariaceae family. The most significant is digitoxin, a very toxic substance that builds up in the body\u0000and is impenetrable in water. For millennia, people have utilized the medication Digitalis to treat cardiac problems induced by obesity. External\u0000triggers like strenuous exercise, emotional stress, eating, exposure to extreme weather, sexual activity, coffee and alcohol consumption, and use of\u0000cocaine or marijuana temporarily increase the risk of having a myocardial infarction. A person's genetic makeup influences disease progression, the\u0000presence of chronic risk factors, and lifestyle choices. Despite various educational programs, the fight against obesity does not appear to be\u0000successful. According to WHO (World Health Organisation) statistics, 13 percent of adults over the age of 18 are obese, and 39 percent are\u0000overweight. Being overweight or obese significantly raises the chance of developing disorders, including coronary heart disease. Digitalis is\u0000primarily used to treat heart conditions. It encourages and stimulates the action of all muscle tissues in cases of clogged heart failure. The herb\u0000improves heart nutrient absorption by forcing more blood into the coronaries. Digitalis aids in the repair and regulation of the heart's function when\u0000blood circulation is hampered.\u0000","PeriodicalId":479738,"journal":{"name":"Current Indian Science","volume":"6 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139004729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Some Versatile Medicinal Plants for Healing Wounds: A Review 一些治疗伤口的多功能药用植物:综述
Pub Date : 2023-12-08 DOI: 10.2174/012210299x257271231124075042
Raj Kumari, Meenakshi Sharma, Abhilasha Mittal, Gauri Goel
The cellular and biochemical stages of the wound-healing process are interrelated and work to repair the wound. The body heals wounds in stages,and each stage that is postponed raises the risk of microbial infection. The time needed for healing can be sped up, and unwanted events can bereduced to improve wound healing. To aid in the healing of the wounds, the medications are administered locally or systemically. In order topromote wound healing, antibiotics, antiseptics, desloughing agents, extracts, etc. have been employed. Due to their adverse effects, severalsynthetic medications are subject to restrictions. Investigation, identification, and formulation of plants or plant-derived combinations are requiredfor the management and therapy of wound healing. Because they have fewer adverse effects and have been used to treat wounds for a longerperiod, medicinal plants are becoming more popular for use in wound healing. According to studies, medicinal herbs help diabetic, infected, andopened wounds heal more quickly. It has been claimed that medicinal herbs can speed up wound healing through a variety of processes. Manymedicinal plants, including Allium sativum, Commiphora myrrha, Curcuma longa (L.), Rauwolfia serpentia, and Vateria indica, havedemonstrated the ability to treat wounds.
伤口愈合过程中的细胞和生化阶段相互关联,共同修复伤口。人体的伤口愈合是分阶段进行的,每一阶段的延迟都会增加微生物感染的风险。愈合所需的时间可以加快,不必要的事件可以减少,以提高伤口愈合。为了帮助伤口愈合,药物可以局部或全身使用。为了促进伤口愈合,使用了抗生素、防腐剂、脱屑剂、提取物等。由于它们的副作用,一些合成药物受到限制。伤口愈合的管理和治疗需要对植物或植物衍生的组合进行调查、鉴定和配方。由于它们的副作用较少,并且用于治疗伤口的时间较长,药用植物在伤口愈合方面越来越受欢迎。根据研究,草药可以帮助糖尿病、感染和伤口愈合得更快。据说草药可以通过多种过程加速伤口愈合。许多药用植物,包括葱,没药,姜黄(L.),狼尾草,和印度缬草,已经证明了治疗伤口的能力。
{"title":"Some Versatile Medicinal Plants for Healing Wounds: A Review","authors":"Raj Kumari, Meenakshi Sharma, Abhilasha Mittal, Gauri Goel","doi":"10.2174/012210299x257271231124075042","DOIUrl":"https://doi.org/10.2174/012210299x257271231124075042","url":null,"abstract":"\u0000\u0000The cellular and biochemical stages of the wound-healing process are interrelated and work to repair the wound. The body heals wounds in stages,\u0000and each stage that is postponed raises the risk of microbial infection. The time needed for healing can be sped up, and unwanted events can be\u0000reduced to improve wound healing. To aid in the healing of the wounds, the medications are administered locally or systemically. In order to\u0000promote wound healing, antibiotics, antiseptics, desloughing agents, extracts, etc. have been employed. Due to their adverse effects, several\u0000synthetic medications are subject to restrictions. Investigation, identification, and formulation of plants or plant-derived combinations are required\u0000for the management and therapy of wound healing. Because they have fewer adverse effects and have been used to treat wounds for a longer\u0000period, medicinal plants are becoming more popular for use in wound healing. According to studies, medicinal herbs help diabetic, infected, and\u0000opened wounds heal more quickly. It has been claimed that medicinal herbs can speed up wound healing through a variety of processes. Many\u0000medicinal plants, including Allium sativum, Commiphora myrrha, Curcuma longa (L.), Rauwolfia serpentia, and Vateria indica, have\u0000demonstrated the ability to treat wounds.\u0000","PeriodicalId":479738,"journal":{"name":"Current Indian Science","volume":"81 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138586837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-effectiveness of Dementia Medication 痴呆症药物的成本效益
Pub Date : 2023-12-08 DOI: 10.2174/012210299x259911231128112915
Nikita Khera, Rojin G Raj, Ranjeet Kumar, Megha Bajaj, Bintoo Sharma, Harsh Tyagi, Josmy Maria Job
Aim:This review has examined and organized the available research on dementia medication care costs. Although the accessible database in this area isgrowing and is still quite limited, there are many clear scientific methods.Objective:The use of Memantine, a non-competitive antagonist with low to moderate affinity for the NMDA (N-methyl-D-aspartate) receptor, has beenapproved for the treatment of mild to moderately severe Alzheimer's disease (AD). The efficacy of cholinesterase inhibitors (ChEIs) in thetreatment of dementia varies depending on the drug type and ease of administration. Numerous techniques have been employed to evaluate thequality of life (QOL) of individuals suffering from dementia. QOL data is a well-established measure of an intervention's effectiveness. Up to now,cost-effectiveness studies have concentrated on both pharmaceutical and non-pharmacological therapy. Each unit of QoL-AD improvement costsUSD27.82578 at mean values.Methods:Searches were conducted to observe studies of the pharmacoeconomic impact of dementia medications with the help of previous articles publishedin journals and collected from Google Scholar with name search dementia or Alzheimer's cross-referenced with pharmacoeconomic or costs andeffectiveness.
目的:本综述对现有的有关痴呆症药物治疗费用的研究进行了审查和整理。目的:美金刚是一种对 NMDA(N-甲基-D-天冬氨酸)受体具有中低度亲和力的非竞争性拮抗剂,已被批准用于治疗轻度至中度重度阿尔茨海默病(AD)。胆碱酯酶抑制剂(ChEIs)治疗痴呆症的疗效因药物类型和给药难易程度而异。评估痴呆症患者生活质量(QOL)的方法有很多。QOL 数据是衡量干预效果的一个行之有效的指标。迄今为止,成本效益研究主要集中在药物疗法和非药物疗法上。方法:借助以往发表在期刊上的文章,从谷歌学术网站上搜索痴呆症或阿尔茨海默氏症的名称,并与药物经济学或成本和效果交叉引用,观察有关痴呆症药物对药物经济学影响的研究。
{"title":"Cost-effectiveness of Dementia Medication","authors":"Nikita Khera, Rojin G Raj, Ranjeet Kumar, Megha Bajaj, Bintoo Sharma, Harsh Tyagi, Josmy Maria Job","doi":"10.2174/012210299x259911231128112915","DOIUrl":"https://doi.org/10.2174/012210299x259911231128112915","url":null,"abstract":"\u0000\u0000Aim:\u0000This review has examined and organized the available research on dementia medication care costs. Although the accessible database in this area is\u0000growing and is still quite limited, there are many clear scientific methods.\u0000Objective:\u0000The use of Memantine, a non-competitive antagonist with low to moderate affinity for the NMDA (N-methyl-D-aspartate) receptor, has been\u0000approved for the treatment of mild to moderately severe Alzheimer's disease (AD). The efficacy of cholinesterase inhibitors (ChEIs) in the\u0000treatment of dementia varies depending on the drug type and ease of administration. Numerous techniques have been employed to evaluate the\u0000quality of life (QOL) of individuals suffering from dementia. QOL data is a well-established measure of an intervention's effectiveness. Up to now,\u0000cost-effectiveness studies have concentrated on both pharmaceutical and non-pharmacological therapy. Each unit of QoL-AD improvement costs\u0000USD27.82578 at mean values.\u0000Methods:\u0000Searches were conducted to observe studies of the pharmacoeconomic impact of dementia medications with the help of previous articles published\u0000in journals and collected from Google Scholar with name search dementia or Alzheimer's cross-referenced with pharmacoeconomic or costs and\u0000effectiveness.\u0000","PeriodicalId":479738,"journal":{"name":"Current Indian Science","volume":"418 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139010938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MECHANISTIC INSIGHT OF INNOVATIVE BIOMARKERS FOR SCREENING OF TYPE II DIABETES MELLITUS 从机理上洞察用于筛查 II 型糖尿病的创新生物标志物
Pub Date : 2023-12-08 DOI: 10.2174/012210299x257270231127062630
Shubhdeep Yadav, Neelam singh
Diabetes mellitus is a complex, chronic disorder characterised by increased blood glucose levels caused by cellular resistance to insulin action, insufficient insulin production by pancreatic -cells, or both. Type 2 diabetes (T2DM), the most prevalent form of diabetes mellitus, accounts for almost 90% of all cases globally. T2DM is more common in middle-aged and older people, and its causes are multifaceted. The use of successful and cost-effective solutions for diabetes mellitus screening is critical to ensuring early identification and minimising patients' risk of acquiring life-threatening illness complications. Identifying novel biomarkers and test methods for diabetes mellitus is therefore critical in order establish robust, non-invasive, painless, highly sensitive, and precise screening procedures. This review focuses on the recent finding of new clinically validated and innovative biomarkers, as well as methods for determining them, which provide cost-effective options for T2DM screening and early detection.
糖尿病是一种复杂的慢性疾病,其特点是由于细胞对胰岛素作用的抵抗、胰腺细胞分泌的胰岛素不足或两者兼而有之而导致血糖水平升高。2 型糖尿病(T2DM)是最常见的糖尿病形式,几乎占全球所有病例的 90%。T2DM 在中老年人中更为常见,其病因是多方面的。使用成功且具有成本效益的解决方案进行糖尿病筛查,对于确保早期识别和最大限度地降低患者罹患危及生命的疾病并发症的风险至关重要。因此,为了建立健全、无创、无痛、高灵敏度和精确的筛查程序,确定新型糖尿病生物标志物和检测方法至关重要。本综述重点介绍最近发现的经临床验证的创新生物标志物及其测定方法,它们为 T2DM 筛查和早期检测提供了具有成本效益的选择。
{"title":"MECHANISTIC INSIGHT OF INNOVATIVE BIOMARKERS FOR SCREENING OF TYPE II DIABETES MELLITUS","authors":"Shubhdeep Yadav, Neelam singh","doi":"10.2174/012210299x257270231127062630","DOIUrl":"https://doi.org/10.2174/012210299x257270231127062630","url":null,"abstract":"\u0000\u0000Diabetes mellitus is a complex, chronic disorder characterised by increased blood glucose levels caused by cellular resistance to insulin action, insufficient insulin production by pancreatic -cells, or both. Type 2 diabetes (T2DM), the most prevalent form of diabetes mellitus, accounts for almost 90% of all cases globally. T2DM is more common in middle-aged and older people, and its causes are multifaceted. The use of successful and cost-effective solutions for diabetes mellitus screening is critical to ensuring early identification and minimising patients' risk of acquiring life-threatening illness complications. Identifying novel biomarkers and test methods for diabetes mellitus is therefore critical in order establish robust, non-invasive, painless, highly sensitive, and precise screening procedures. This review focuses on the recent finding of new clinically validated and innovative biomarkers, as well as methods for determining them, which provide cost-effective options for T2DM screening and early detection.\u0000","PeriodicalId":479738,"journal":{"name":"Current Indian Science","volume":"387 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139010973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Regulatory Framework and Challenges for the Approval of ComplexGenerics in the US and the EU 美国和欧盟审批复杂非专利药的现行监管框架和挑战
Pub Date : 2023-12-08 DOI: 10.2174/012210299x269535231203164108
Sharvari Patil, Sandeep Kumar, Dasari Mallikarjuna Rao, Kishore Rewatkar
The pharmaceutical industry is witnessing a growing demand for complex generic products, which are generic versions of drugs that possesscomplex formulations, delivery systems, or active ingredients. However, the approval process for these complex generic products poses uniquechallenges compared to traditional generics. There is no specific regulatory procedure available for the approval of complex generics, unlike smallmoleculegenerics and biosimilars. This led to controversial arguments in the past about the scientific evidence needed for applications, which ledto lengthy approval processes. The regulatory frameworks that are currently being used for complex generics are debatable and unclear.Complexity in the molecular structure, mechanism of action, route of delivery, and complex manufacturing process makes proving bioequivalenceand pharmaceutical equivalence difficult. There is a need for harmonization of the regulatory framework by the agencies to help the genericmanufacturers by providing scientific advice, defining the submission requirements for complex products, and fastening the approval process.This review begins by discussing the regulatory landscape surrounding complex generic products in various regions, including the United Statesand Europe. It examines the specific guidelines and requirements set forth by regulatory authorities to ensure the safety, efficacy, and quality ofthese products. Additionally, the review explores the differences in terminology and definitions used to classify complex generics across differentjurisdictions. Furthermore, it delves into the challenges faced by both regulatory agencies and pharmaceutical companies in evaluating andapproving complex generic products. These challenges include establishing appropriate bioequivalence criteria, determining interchangeabilitywith the reference product, addressing patent and exclusivity issues, and ensuring consistent quality throughout the product lifecycle. The impact ofthese challenges on market entry and competition is also discussed. The review highlights the need for harmonization and streamlining ofregulations for complex generic products worldwide. It emphasizes the importance of clear and consistent guidelines to enable timely approvals,foster innovation, and facilitate patient access to affordable alternatives.
制药行业对复杂非专利产品的需求日益增长,这些产品是拥有复杂配方、给药系统或活性成分的药物的非专利版本。然而,与传统仿制药相比,这些复杂仿制药的审批程序带来了独特的挑战。与小分子仿制药和生物仿制药不同,复杂仿制药的审批没有专门的监管程序。这导致过去在申请所需的科学证据问题上存在争议,从而导致审批过程漫长。分子结构、作用机制、给药途径的复杂性以及复杂的生产工艺使得证明生物等效性和药物等效性变得十分困难。各机构有必要协调监管框架,通过提供科学建议、确定复杂产品的申报要求和加快审批流程来帮助仿制药生产商。本综述首先讨论了美国和欧洲等不同地区围绕复杂仿制药的监管情况。本综述首先讨论了各地区(包括美国和欧洲)对复杂非专利产品的监管情况,研究了监管机构为确保这些产品的安全性、有效性和质量而制定的具体准则和要求。此外,报告还探讨了不同司法管辖区在对复杂仿制药进行分类时所使用的术语和定义的差异。此外,它还深入探讨了监管机构和制药公司在评估和批准复杂仿制药产品时所面临的挑战。这些挑战包括建立适当的生物等效性标准、确定与参比产品的互换性、解决专利和排他性问题,以及确保整个产品生命周期的质量一致性。报告还讨论了这些挑战对市场进入和竞争的影响。审查强调了协调和简化全球复杂非专利产品监管的必要性。它强调了明确一致的指导原则对于及时审批、促进创新和方便患者获得负担得起的替代品的重要性。
{"title":"Current Regulatory Framework and Challenges for the Approval of Complex\u0000Generics in the US and the EU","authors":"Sharvari Patil, Sandeep Kumar, Dasari Mallikarjuna Rao, Kishore Rewatkar","doi":"10.2174/012210299x269535231203164108","DOIUrl":"https://doi.org/10.2174/012210299x269535231203164108","url":null,"abstract":"\u0000\u0000The pharmaceutical industry is witnessing a growing demand for complex generic products, which are generic versions of drugs that possess\u0000complex formulations, delivery systems, or active ingredients. However, the approval process for these complex generic products poses unique\u0000challenges compared to traditional generics. There is no specific regulatory procedure available for the approval of complex generics, unlike smallmolecule\u0000generics and biosimilars. This led to controversial arguments in the past about the scientific evidence needed for applications, which led\u0000to lengthy approval processes. The regulatory frameworks that are currently being used for complex generics are debatable and unclear.\u0000Complexity in the molecular structure, mechanism of action, route of delivery, and complex manufacturing process makes proving bioequivalence\u0000and pharmaceutical equivalence difficult. There is a need for harmonization of the regulatory framework by the agencies to help the generic\u0000manufacturers by providing scientific advice, defining the submission requirements for complex products, and fastening the approval process.\u0000This review begins by discussing the regulatory landscape surrounding complex generic products in various regions, including the United States\u0000and Europe. It examines the specific guidelines and requirements set forth by regulatory authorities to ensure the safety, efficacy, and quality of\u0000these products. Additionally, the review explores the differences in terminology and definitions used to classify complex generics across different\u0000jurisdictions. Furthermore, it delves into the challenges faced by both regulatory agencies and pharmaceutical companies in evaluating and\u0000approving complex generic products. These challenges include establishing appropriate bioequivalence criteria, determining interchangeability\u0000with the reference product, addressing patent and exclusivity issues, and ensuring consistent quality throughout the product lifecycle. The impact of\u0000these challenges on market entry and competition is also discussed. The review highlights the need for harmonization and streamlining of\u0000regulations for complex generic products worldwide. It emphasizes the importance of clear and consistent guidelines to enable timely approvals,\u0000foster innovation, and facilitate patient access to affordable alternatives.\u0000","PeriodicalId":479738,"journal":{"name":"Current Indian Science","volume":"232 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139011036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comprehensive Review of Abroma Augusta (Devil's Cotton): PhytochemicalConstituents, Ethnomedicinal Applications, and Pharmacological Properties Abroma Augusta(魔鬼棉)综述:植物化学成分、民族医药应用和药理特性
Pub Date : 2023-12-08 DOI: 10.2174/012210299x265912231130060959
A. Balkrishna, Shailja Mishra, Ashish Dhyani, Priyanka Saini, V. Arya, Nidhi Sharma
The nutritional and therapeutic potential of medicinal plants is constantly being investigated. This is especially relevant in today's world, where anincreasing number of people are turning to complementary and alternative therapies to address their health-related concerns. Traditionalknowledge, as a valuable resource, plays a crucial role in the development of new herbal medicines. Abroma augusta stands out as one suchmedicinal plant that has a rich history of use in traditional medicine. It has been employed to address a wide spectrum of health issues, includingdiabetes, menstrual irregularities, respiratory problems, musculoskeletal disorders, urinary ailments, and sexual dysfunctions, among others. Whilevarious parts of this plant species are believed to possess pharmacological properties, the active compounds and underlying mechanisms remainlargely unexplored. To facilitate the development of innovative drugs for the benefit of individuals, this study places significant emphasis ondelving into the phytochemical and ethnomedicinal attributes of A. augusta. Moreover, it seeks to bolster its findings with scientifically validatedpharmacological investigations conducted through both in vivo and in vitro methodologies.
人们一直在研究药用植物的营养和治疗潜力。这在当今世界尤为重要,因为越来越多的人开始采用补充和替代疗法来解决与健康有关的问题。传统知识作为一种宝贵的资源,在新草药的开发过程中发挥着至关重要的作用。Abroma augusta 就是这样一种在传统医学中有着丰富使用历史的药用植物。它被广泛用于解决各种健康问题,包括糖尿病、月经不调、呼吸系统问题、肌肉骨骼疾病、泌尿系统疾病和性功能障碍等。虽然人们相信这种植物的各个部分都具有药理特性,但其活性化合物和潜在机制仍未得到充分探索。为了促进创新药物的开发,造福人类,本研究将重点放在深入研究 A. augusta 的植物化学成分和民族药用特性上。此外,它还试图通过体内和体外方法进行科学验证的药理学研究来支持其研究结果。
{"title":"A Comprehensive Review of Abroma Augusta (Devil's Cotton): Phytochemical\u0000Constituents, Ethnomedicinal Applications, and Pharmacological Properties","authors":"A. Balkrishna, Shailja Mishra, Ashish Dhyani, Priyanka Saini, V. Arya, Nidhi Sharma","doi":"10.2174/012210299x265912231130060959","DOIUrl":"https://doi.org/10.2174/012210299x265912231130060959","url":null,"abstract":"\u0000\u0000The nutritional and therapeutic potential of medicinal plants is constantly being investigated. This is especially relevant in today's world, where an\u0000increasing number of people are turning to complementary and alternative therapies to address their health-related concerns. Traditional\u0000knowledge, as a valuable resource, plays a crucial role in the development of new herbal medicines. Abroma augusta stands out as one such\u0000medicinal plant that has a rich history of use in traditional medicine. It has been employed to address a wide spectrum of health issues, including\u0000diabetes, menstrual irregularities, respiratory problems, musculoskeletal disorders, urinary ailments, and sexual dysfunctions, among others. While\u0000various parts of this plant species are believed to possess pharmacological properties, the active compounds and underlying mechanisms remain\u0000largely unexplored. To facilitate the development of innovative drugs for the benefit of individuals, this study places significant emphasis on\u0000delving into the phytochemical and ethnomedicinal attributes of A. augusta. Moreover, it seeks to bolster its findings with scientifically validated\u0000pharmacological investigations conducted through both in vivo and in vitro methodologies.\u0000","PeriodicalId":479738,"journal":{"name":"Current Indian Science","volume":"104 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139011124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review on Psoriasis Pathophysiology, Clinical Appearance, andPharmacotherapeutic Interventions 牛皮癣病理生理学、临床表现和药物治疗干预综述
Pub Date : 2023-12-08 DOI: 10.2174/012210299x256032231127060853
Deepak Kumar, Sagarika Majhi, Meenakshi Sharma
A chronic skin condition called psoriasis can manifest as plaque, flexural, guttate, pustular, and erythrodermic lesions, among other clinicalsymptoms. Sixty million people are believed to be affected by psoriasis worldwide. In India, the frequency ranges from 0.44 to 2.8%, with malesaffected two times more frequently than females in their third or fourth decade of life. An immune-mediated inflammation condition with a sizablegenetic component is psoriasis. Due to its connection to psoriatic arthritis and the increased prevalence of cardiometabolic, hepatic, and psychiatricproblems, a thorough and interdisciplinary strategy for treatment is required. Corticosteroids and analogs of vitamin D are examples of topicaltreatments for psoriasis. Phototherapy includes NB-UVB, psoralen, and ultraviolet radiation (PUVA). Standard systemic treatments includemethotrexate, acitretin, and ciclosporin. This disease is useful for physicians and scientists since it might be used as a model for research into theunderlying causes of chronic inflammation. It is also crucial for clinical trial scientists as a first-choice disease indication for preliminary researchof new pathogenesis-based treatment approaches. This review covers both the therapeutic choices that have resulted from the analysis of theaggressive psoriatic pathways and the processes involved in the onset and progression of the disease. We start by writing regarding the importantcell kinds and inflammatory mechanisms that initiate and maintain psoriatic inflammation. Next, we discuss how skin flora interacts with heredity,related epigenetic processes, and the pathogenesis of psoriasis. Finally, we provide a thorough analysis of recently targeted medications as well aswell-known, extensively used treatments.
银屑病是一种慢性皮肤病,可表现为斑块状、挠状、凹陷性、脓疱性和红皮病性皮损以及其他临床症状。据信,全世界有 6000 万人患有银屑病。在印度,发病率从 0.44%到 2.8%不等,男性患者是女性患者的两倍,年龄在三四十岁之间。银屑病是一种免疫介导的炎症,具有相当大的遗传因素。由于银屑病与银屑病关节炎有关联,而且心血管代谢、肝脏和精神问题的发病率增加,因此需要采取全面的跨学科治疗策略。皮质类固醇激素和维生素 D 类似物是银屑病的局部治疗方法。光疗包括 NB-UVB、补骨脂素和紫外线辐射(PUVA)。标准的全身治疗包括氨甲喋呤、阿曲汀和环孢素。这种疾病对医生和科学家非常有用,因为它可以作为研究慢性炎症根本原因的模型。对于临床试验科学家来说,这种疾病也是至关重要的,因为它是初步研究基于发病机制的新治疗方法的首选疾病适应症。本综述涵盖了对侵袭性银屑病发病途径的分析所得出的治疗选择,以及该疾病的发病和进展过程。首先,我们将介绍引发和维持银屑病炎症的重要细胞类型和炎症机制。接下来,我们将讨论皮肤菌群如何与遗传、相关的表观遗传过程以及银屑病的发病机制相互作用。最后,我们对最近的靶向药物以及众所周知的、广泛使用的治疗方法进行了深入分析。
{"title":"A Review on Psoriasis Pathophysiology, Clinical Appearance, and\u0000Pharmacotherapeutic Interventions","authors":"Deepak Kumar, Sagarika Majhi, Meenakshi Sharma","doi":"10.2174/012210299x256032231127060853","DOIUrl":"https://doi.org/10.2174/012210299x256032231127060853","url":null,"abstract":"\u0000\u0000A chronic skin condition called psoriasis can manifest as plaque, flexural, guttate, pustular, and erythrodermic lesions, among other clinical\u0000symptoms. Sixty million people are believed to be affected by psoriasis worldwide. In India, the frequency ranges from 0.44 to 2.8%, with males\u0000affected two times more frequently than females in their third or fourth decade of life. An immune-mediated inflammation condition with a sizable\u0000genetic component is psoriasis. Due to its connection to psoriatic arthritis and the increased prevalence of cardiometabolic, hepatic, and psychiatric\u0000problems, a thorough and interdisciplinary strategy for treatment is required. Corticosteroids and analogs of vitamin D are examples of topical\u0000treatments for psoriasis. Phototherapy includes NB-UVB, psoralen, and ultraviolet radiation (PUVA). Standard systemic treatments include\u0000methotrexate, acitretin, and ciclosporin. This disease is useful for physicians and scientists since it might be used as a model for research into the\u0000underlying causes of chronic inflammation. It is also crucial for clinical trial scientists as a first-choice disease indication for preliminary research\u0000of new pathogenesis-based treatment approaches. This review covers both the therapeutic choices that have resulted from the analysis of the\u0000aggressive psoriatic pathways and the processes involved in the onset and progression of the disease. We start by writing regarding the important\u0000cell kinds and inflammatory mechanisms that initiate and maintain psoriatic inflammation. Next, we discuss how skin flora interacts with heredity,\u0000related epigenetic processes, and the pathogenesis of psoriasis. Finally, we provide a thorough analysis of recently targeted medications as well as\u0000well-known, extensively used treatments.\u0000","PeriodicalId":479738,"journal":{"name":"Current Indian Science","volume":"176 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139010686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Indian Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1